PDB Short entry for 5VRP HEADER HYDROLASE/HYDROLASE INHIBITOR 11-MAY-17 5VRP TITLE CRYSTAL STRUCTURE OF HUMAN RENIN IN COMPLEX WITH A TITLE 2 BIPHENYLPIPDERIDINYLCARBINOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 70-406; COMPND 5 SYNONYM: ANGIOTENSINOGENASE; COMPND 6 EC: 3.4.23.15; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: REN; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK-F KEYWDS RENIN INHIBITOR, BIPHENYL, HYPERTENSION, CYP 3A4, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.CONCHA,B.ZHAO REVDAT 3 29-JUL-20 5VRP 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE REVDAT 2 25-OCT-17 5VRP 1 JRNL REVDAT 1 18-OCT-17 5VRP 0 JRNL AUTH B.G.LAWHORN,T.TRAN,V.S.HONG,L.A.MORGAN,B.T.LE,M.R.HARPEL, JRNL AUTH 2 L.JOLIVETTE,E.DIAZ,B.SCHWARTZ,J.W.GROSS,T.TOMASZEK,S.SEMUS, JRNL AUTH 3 N.CONCHA,A.SMALLWOOD,D.A.HOLT,L.S.KALLANDER JRNL TITL DISCOVERY OF RENIN INHIBITORS CONTAINING A SIMPLE ASPARTATE JRNL TITL 2 BINDING MOIETY THAT IMPARTS REDUCED P450 INHIBITION. JRNL REF BIOORG. MED. CHEM. LETT. V. 27 4838 2017 JRNL REFN ESSN 1464-3405 JRNL PMID 28985999 JRNL DOI 10.1016/J.BMCL.2017.09.046 REMARK 2 REMARK 2 RESOLUTION. 3.22 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.22 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.080 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.6 REMARK 3 NUMBER OF REFLECTIONS : 11935 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.246 REMARK 3 R VALUE (WORKING SET) : 0.246 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.900 REMARK 3 FREE R VALUE TEST SET COUNT : 704 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.9840 - 5.4910 0.98 2601 165 0.2195 0.2803 REMARK 3 2 5.4910 - 4.3659 0.96 2441 160 0.2030 0.2210 REMARK 3 3 4.3659 - 3.8163 0.87 2177 141 0.2517 0.2367 REMARK 3 4 3.8163 - 3.4683 0.81 2013 112 0.3095 0.2901 REMARK 3 5 3.4683 - 3.2203 0.81 1999 126 0.3329 0.3332 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.900 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 5348 REMARK 3 ANGLE : 0.664 7279 REMARK 3 CHIRALITY : 0.048 813 REMARK 3 PLANARITY : 0.003 915 REMARK 3 DIHEDRAL : 17.123 3052 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ( CHAIN A AND RESID 70:326 ) REMARK 3 ORIGIN FOR THE GROUP (A): 29.6420 46.4823 8.9386 REMARK 3 T TENSOR REMARK 3 T11: 0.3220 T22: 0.2721 REMARK 3 T33: 0.3808 T12: -0.0096 REMARK 3 T13: 0.0195 T23: -0.1119 REMARK 3 L TENSOR REMARK 3 L11: 3.2322 L22: 0.7767 REMARK 3 L33: 3.1533 L12: -0.6084 REMARK 3 L13: 1.9199 L23: -1.0142 REMARK 3 S TENSOR REMARK 3 S11: -0.0052 S12: -0.0739 S13: 0.1143 REMARK 3 S21: 0.0858 S22: 0.0752 S23: -0.0443 REMARK 3 S31: -0.2297 S32: -0.0073 S33: -0.0694 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: ( CHAIN B AND RESID 70:326 ) REMARK 3 ORIGIN FOR THE GROUP (A): 14.6234 19.3138 28.2070 REMARK 3 T TENSOR REMARK 3 T11: 0.3907 T22: 0.4875 REMARK 3 T33: 0.2721 T12: 0.1075 REMARK 3 T13: -0.0057 T23: 0.0741 REMARK 3 L TENSOR REMARK 3 L11: 3.0607 L22: 2.4762 REMARK 3 L33: 2.6084 L12: 0.6589 REMARK 3 L13: -0.5729 L23: -0.1306 REMARK 3 S TENSOR REMARK 3 S11: -0.0752 S12: -0.3078 S13: 0.1842 REMARK 3 S21: 0.2129 S22: 0.2453 S23: 0.2354 REMARK 3 S31: -0.2996 S32: -0.5061 S33: -0.0954 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5VRP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-MAY-17. REMARK 100 THE DEPOSITION ID IS D_1000227912. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13533 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.220 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1 UL OF 200 MM INHIBITOR SOLUTION IN REMARK 280 DMSO WAS ADDED TO 100 UL OF PROTEIN.. THE INHIBITOR WAS SOLUBLE REMARK 280 IN THE PROTEIN SOLUTION. THE INHIBITOR STOCK WAS FRESHLY MADE. REMARK 280 THE SAMPLE WAS INCUBATED FOR 3 HR ON ICE PRIOR TO SETTING UP THE REMARK 280 PLATES. 2 ML PROTEIN, 2 ML WELL HANGING DROPS WERE SET UP IN THE REMARK 280 COLD. STREAK SEEDED THE NEXT DAY WITH CRUSHED CRYSTALS FROM THE REMARK 280 LAST TIME., PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.16700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.26450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 49.96650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 73.26450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.16700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 49.96650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 233 REMARK 465 ASN A 234 REMARK 465 SER A 235 REMARK 465 GLN A 236 REMARK 465 GLU B 233 REMARK 465 ASN B 234 REMARK 465 SER B 235 REMARK 465 GLN B 236 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 71 CG OD1 ND2 REMARK 470 THR A 73 OG1 CG2 REMARK 470 TYR A 126 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A 144 CG CD OE1 OE2 REMARK 470 ARG A 205 CD NE CZ NH1 NH2 REMARK 470 SER A 232 OG REMARK 470 GLN A 250 CG CD OE1 NE2 REMARK 470 LYS A 272 CD CE NZ REMARK 470 SER A 278 OG REMARK 470 SER A 279 OG REMARK 470 THR A 280 OG1 CG2 REMARK 470 GLU A 306 CG CD OE1 OE2 REMARK 470 LYS A 307 CE NZ REMARK 470 LYS A 315 CG CD CE NZ REMARK 470 VAL A 322 CG1 CG2 REMARK 470 LYS A 324 CG CD CE NZ REMARK 470 GLU A 327 CG CD OE1 OE2 REMARK 470 GLU A 354 CG CD OE1 OE2 REMARK 470 LYS A 359 CG CD CE NZ REMARK 470 LYS A 360 CG CD CE NZ REMARK 470 THR B 72 OG1 CG2 REMARK 470 ILE B 77 CG1 CG2 CD1 REMARK 470 SER B 108 OG REMARK 470 LYS B 116 CG CD CE NZ REMARK 470 SER B 118 OG REMARK 470 ARG B 119 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 120 CG CD1 CD2 REMARK 470 SER B 136 OG REMARK 470 LYS B 139 CE NZ REMARK 470 ARG B 148 CZ NH1 NH2 REMARK 470 GLU B 179 CG CD OE1 OE2 REMARK 470 ARG B 230 NE CZ NH1 NH2 REMARK 470 LEU B 238 CG CD1 CD2 REMARK 470 GLU B 284 CG CD OE1 OE2 REMARK 470 ASP B 285 CG OD1 OD2 REMARK 470 GLN B 353 N REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 HIS B 367 O23 9JD B 503 2.07 REMARK 500 NE2 HIS A 367 O23 9JD A 504 2.09 REMARK 500 OD2 ASP A 104 N40 9JD A 503 2.14 REMARK 500 OH TYR A 297 O34 9JD A 504 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 141 -66.86 -129.04 REMARK 500 ASP B 83 -2.69 63.90 REMARK 500 ASN B 141 -66.66 -130.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5V8V RELATED DB: PDB REMARK 900 RELATED ID: 5VPM RELATED DB: PDB DBREF 5VRP A 70 406 UNP P00797 RENI_HUMAN 70 406 DBREF 5VRP B 70 406 UNP P00797 RENI_HUMAN 70 406 SEQRES 1 A 337 GLY ASN THR THR SER SER VAL ILE LEU THR ASN TYR MET SEQRES 2 A 337 ASP THR GLN TYR TYR GLY GLU ILE GLY ILE GLY THR PRO SEQRES 3 A 337 PRO GLN THR PHE LYS VAL VAL PHE ASP THR GLY SER SER SEQRES 4 A 337 ASN VAL TRP VAL PRO SER SER LYS CYS SER ARG LEU TYR SEQRES 5 A 337 THR ALA CYS VAL TYR HIS LYS LEU PHE ASP ALA SER ASP SEQRES 6 A 337 SER SER SER TYR LYS HIS ASN GLY THR GLU LEU THR LEU SEQRES 7 A 337 ARG TYR SER THR GLY THR VAL SER GLY PHE LEU SER GLN SEQRES 8 A 337 ASP ILE ILE THR VAL GLY GLY ILE THR VAL THR GLN MET SEQRES 9 A 337 PHE GLY GLU VAL THR GLU MET PRO ALA LEU PRO PHE MET SEQRES 10 A 337 LEU ALA GLU PHE ASP GLY VAL VAL GLY MET GLY PHE ILE SEQRES 11 A 337 GLU GLN ALA ILE GLY ARG VAL THR PRO ILE PHE ASP ASN SEQRES 12 A 337 ILE ILE SER GLN GLY VAL LEU LYS GLU ASP VAL PHE SER SEQRES 13 A 337 PHE TYR TYR ASN ARG ASP SER GLU ASN SER GLN SER LEU SEQRES 14 A 337 GLY GLY GLN ILE VAL LEU GLY GLY SER ASP PRO GLN HIS SEQRES 15 A 337 TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE LYS THR SEQRES 16 A 337 GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SER VAL GLY SEQRES 17 A 337 SER SER THR LEU LEU CYS GLU ASP GLY CYS LEU ALA LEU SEQRES 18 A 337 VAL ASP THR GLY ALA SER TYR ILE SER GLY SER THR SER SEQRES 19 A 337 SER ILE GLU LYS LEU MET GLU ALA LEU GLY ALA LYS LYS SEQRES 20 A 337 ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU GLY PRO SEQRES 21 A 337 THR LEU PRO ASP ILE SER PHE HIS LEU GLY GLY LYS GLU SEQRES 22 A 337 TYR THR LEU THR SER ALA ASP TYR VAL PHE GLN GLU SER SEQRES 23 A 337 TYR SER SER LYS LYS LEU CYS THR LEU ALA ILE HIS ALA SEQRES 24 A 337 MET ASP ILE PRO PRO PRO THR GLY PRO THR TRP ALA LEU SEQRES 25 A 337 GLY ALA THR PHE ILE ARG LYS PHE TYR THR GLU PHE ASP SEQRES 26 A 337 ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA ARG SEQRES 1 B 337 GLY ASN THR THR SER SER VAL ILE LEU THR ASN TYR MET SEQRES 2 B 337 ASP THR GLN TYR TYR GLY GLU ILE GLY ILE GLY THR PRO SEQRES 3 B 337 PRO GLN THR PHE LYS VAL VAL PHE ASP THR GLY SER SER SEQRES 4 B 337 ASN VAL TRP VAL PRO SER SER LYS CYS SER ARG LEU TYR SEQRES 5 B 337 THR ALA CYS VAL TYR HIS LYS LEU PHE ASP ALA SER ASP SEQRES 6 B 337 SER SER SER TYR LYS HIS ASN GLY THR GLU LEU THR LEU SEQRES 7 B 337 ARG TYR SER THR GLY THR VAL SER GLY PHE LEU SER GLN SEQRES 8 B 337 ASP ILE ILE THR VAL GLY GLY ILE THR VAL THR GLN MET SEQRES 9 B 337 PHE GLY GLU VAL THR GLU MET PRO ALA LEU PRO PHE MET SEQRES 10 B 337 LEU ALA GLU PHE ASP GLY VAL VAL GLY MET GLY PHE ILE SEQRES 11 B 337 GLU GLN ALA ILE GLY ARG VAL THR PRO ILE PHE ASP ASN SEQRES 12 B 337 ILE ILE SER GLN GLY VAL LEU LYS GLU ASP VAL PHE SER SEQRES 13 B 337 PHE TYR TYR ASN ARG ASP SER GLU ASN SER GLN SER LEU SEQRES 14 B 337 GLY GLY GLN ILE VAL LEU GLY GLY SER ASP PRO GLN HIS SEQRES 15 B 337 TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE LYS THR SEQRES 16 B 337 GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SER VAL GLY SEQRES 17 B 337 SER SER THR LEU LEU CYS GLU ASP GLY CYS LEU ALA LEU SEQRES 18 B 337 VAL ASP THR GLY ALA SER TYR ILE SER GLY SER THR SER SEQRES 19 B 337 SER ILE GLU LYS LEU MET GLU ALA LEU GLY ALA LYS LYS SEQRES 20 B 337 ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU GLY PRO SEQRES 21 B 337 THR LEU PRO ASP ILE SER PHE HIS LEU GLY GLY LYS GLU SEQRES 22 B 337 TYR THR LEU THR SER ALA ASP TYR VAL PHE GLN GLU SER SEQRES 23 B 337 TYR SER SER LYS LYS LEU CYS THR LEU ALA ILE HIS ALA SEQRES 24 B 337 MET ASP ILE PRO PRO PRO THR GLY PRO THR TRP ALA LEU SEQRES 25 B 337 GLY ALA THR PHE ILE ARG LYS PHE TYR THR GLU PHE ASP SEQRES 26 B 337 ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA ARG HET NAG A 501 14 HET SO4 A 502 5 HET 9JD A 503 38 HET 9JD A 504 38 HET NAG B 501 14 HET 9JD B 502 38 HET 9JD B 503 38 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM SO4 SULFATE ION HETNAM 9JD METHYL [(4S)-4-{(3R)-1-[(3S)-4-AMINO-3- HETNAM 2 9JD HYDROXYBUTANOYL]PIPERIDIN-3-YL}-4-(3'-ETHYL-6- HETNAM 3 9JD FLUORO[1,1'-BIPHENYL]-2-YL)-4-HYDROXYBUTYL]CARBAMATE FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 4 SO4 O4 S 2- FORMUL 5 9JD 4(C29 H40 F N3 O5) FORMUL 10 HOH *(H2 O) HELIX 1 AA1 THR A 122 HIS A 127 1 6 HELIX 2 AA2 ASP A 131 SER A 135 5 5 HELIX 3 AA3 PRO A 181 MET A 186 1 6 HELIX 4 AA4 PHE A 198 VAL A 206 5 9 HELIX 5 AA5 PRO A 208 GLY A 217 1 10 HELIX 6 AA6 ASP A 248 GLN A 250 5 3 HELIX 7 AA7 SER A 301 GLY A 313 1 13 HELIX 8 AA8 GLU A 327 LEU A 331 5 5 HELIX 9 AA9 THR A 346 VAL A 351 1 6 HELIX 10 AB1 GLY A 382 LYS A 388 1 7 HELIX 11 AB2 THR B 122 HIS B 127 1 6 HELIX 12 AB3 ASP B 131 SER B 135 5 5 HELIX 13 AB4 PRO B 181 MET B 186 1 6 HELIX 14 AB5 PHE B 198 VAL B 206 5 9 HELIX 15 AB6 PRO B 208 GLN B 216 1 9 HELIX 16 AB7 ASP B 248 GLN B 250 5 3 HELIX 17 AB8 SER B 301 GLY B 313 1 13 HELIX 18 AB9 GLU B 327 LEU B 331 5 5 HELIX 19 AC1 THR B 346 VAL B 351 1 6 HELIX 20 AC2 GLY B 382 LYS B 388 1 7 SHEET 1 AA1 9 LYS A 139 ARG A 148 0 SHEET 2 AA1 9 THR A 153 VAL A 165 -1 O LEU A 158 N GLY A 142 SHEET 3 AA1 9 GLN A 85 ILE A 92 -1 N GLY A 91 O THR A 164 SHEET 4 AA1 9 SER A 74 TYR A 81 -1 N THR A 79 O TYR A 87 SHEET 5 AA1 9 GLY A 240 LEU A 244 -1 O GLY A 240 N LEU A 78 SHEET 6 AA1 9 VAL A 223 TYR A 228 -1 N SER A 225 O VAL A 243 SHEET 7 AA1 9 PHE A 389 ASP A 394 -1 O PHE A 393 N PHE A 224 SHEET 8 AA1 9 ARG A 399 ALA A 405 -1 O GLY A 401 N GLU A 392 SHEET 9 AA1 9 TYR A 252 ASN A 260 -1 N ILE A 259 O ILE A 400 SHEET 1 AA213 LYS A 139 ARG A 148 0 SHEET 2 AA213 THR A 153 VAL A 165 -1 O LEU A 158 N GLY A 142 SHEET 3 AA213 ILE A 168 GLU A 179 -1 O VAL A 170 N ILE A 163 SHEET 4 AA213 TRP A 111 PRO A 113 1 N VAL A 112 O VAL A 177 SHEET 5 AA213 GLY A 192 GLY A 195 -1 O VAL A 193 N TRP A 111 SHEET 6 AA213 GLN A 97 ASP A 104 1 N VAL A 102 O VAL A 194 SHEET 7 AA213 GLN A 85 ILE A 92 -1 N GLY A 88 O VAL A 101 SHEET 8 AA213 SER A 74 TYR A 81 -1 N THR A 79 O TYR A 87 SHEET 9 AA213 GLY A 240 LEU A 244 -1 O GLY A 240 N LEU A 78 SHEET 10 AA213 VAL A 223 TYR A 228 -1 N SER A 225 O VAL A 243 SHEET 11 AA213 PHE A 389 ASP A 394 -1 O PHE A 393 N PHE A 224 SHEET 12 AA213 ARG A 399 ALA A 405 -1 O GLY A 401 N GLU A 392 SHEET 13 AA213 TYR A 252 ASN A 260 -1 N ILE A 259 O ILE A 400 SHEET 1 AA3 4 SER A 279 LEU A 282 0 SHEET 2 AA3 4 GLN A 268 VAL A 276 -1 N VAL A 274 O LEU A 282 SHEET 3 AA3 4 ILE A 334 LEU A 338 -1 O SER A 335 N SER A 275 SHEET 4 AA3 4 LYS A 341 LEU A 345 -1 O TYR A 343 N PHE A 336 SHEET 1 AA4 4 SER A 279 LEU A 282 0 SHEET 2 AA4 4 GLN A 268 VAL A 276 -1 N VAL A 274 O LEU A 282 SHEET 3 AA4 4 CYS A 287 VAL A 291 -1 O CYS A 287 N MET A 271 SHEET 4 AA4 4 TRP A 379 LEU A 381 1 O TRP A 379 N LEU A 290 SHEET 1 AA5 2 ILE A 298 GLY A 300 0 SHEET 2 AA5 2 ILE A 366 ALA A 368 1 O HIS A 367 N ILE A 298 SHEET 1 AA6 3 LYS A 315 LYS A 316 0 SHEET 2 AA6 3 TYR A 321 LYS A 324 -1 O VAL A 322 N LYS A 315 SHEET 3 AA6 3 LEU A 361 THR A 363 -1 O CYS A 362 N VAL A 323 SHEET 1 AA7 9 LYS B 139 ARG B 148 0 SHEET 2 AA7 9 THR B 153 VAL B 165 -1 O GLN B 160 N LYS B 139 SHEET 3 AA7 9 GLN B 85 ILE B 92 -1 N GLY B 91 O THR B 164 SHEET 4 AA7 9 SER B 74 TYR B 81 -1 N TYR B 81 O GLN B 85 SHEET 5 AA7 9 GLY B 240 LEU B 244 -1 O GLY B 240 N LEU B 78 SHEET 6 AA7 9 VAL B 223 TYR B 228 -1 N SER B 225 O VAL B 243 SHEET 7 AA7 9 PHE B 389 ASP B 394 -1 O PHE B 393 N PHE B 224 SHEET 8 AA7 9 ARG B 399 ALA B 405 -1 O GLY B 401 N GLU B 392 SHEET 9 AA7 9 TYR B 252 ASN B 260 -1 N HIS B 257 O PHE B 402 SHEET 1 AA813 LYS B 139 ARG B 148 0 SHEET 2 AA813 THR B 153 VAL B 165 -1 O GLN B 160 N LYS B 139 SHEET 3 AA813 ILE B 168 GLU B 179 -1 O ILE B 168 N VAL B 165 SHEET 4 AA813 TRP B 111 PRO B 113 1 N VAL B 112 O VAL B 177 SHEET 5 AA813 GLY B 192 GLY B 195 -1 O VAL B 193 N TRP B 111 SHEET 6 AA813 GLN B 97 ASP B 104 1 N VAL B 102 O VAL B 194 SHEET 7 AA813 GLN B 85 ILE B 92 -1 N GLY B 88 O VAL B 101 SHEET 8 AA813 SER B 74 TYR B 81 -1 N TYR B 81 O GLN B 85 SHEET 9 AA813 GLY B 240 LEU B 244 -1 O GLY B 240 N LEU B 78 SHEET 10 AA813 VAL B 223 TYR B 228 -1 N SER B 225 O VAL B 243 SHEET 11 AA813 PHE B 389 ASP B 394 -1 O PHE B 393 N PHE B 224 SHEET 12 AA813 ARG B 399 ALA B 405 -1 O GLY B 401 N GLU B 392 SHEET 13 AA813 TYR B 252 ASN B 260 -1 N HIS B 257 O PHE B 402 SHEET 1 AA9 4 SER B 279 LEU B 282 0 SHEET 2 AA9 4 GLN B 268 VAL B 276 -1 N VAL B 276 O SER B 279 SHEET 3 AA9 4 ILE B 334 LEU B 338 -1 O SER B 335 N SER B 275 SHEET 4 AA9 4 LYS B 341 LEU B 345 -1 O LEU B 345 N ILE B 334 SHEET 1 AB1 4 SER B 279 LEU B 282 0 SHEET 2 AB1 4 GLN B 268 VAL B 276 -1 N VAL B 276 O SER B 279 SHEET 3 AB1 4 CYS B 287 VAL B 291 -1 O CYS B 287 N MET B 271 SHEET 4 AB1 4 TRP B 379 LEU B 381 1 O TRP B 379 N LEU B 290 SHEET 1 AB2 2 ILE B 298 GLY B 300 0 SHEET 2 AB2 2 ILE B 366 ALA B 368 1 O HIS B 367 N ILE B 298 SHEET 1 AB3 3 LYS B 315 LYS B 316 0 SHEET 2 AB3 3 TYR B 321 LYS B 324 -1 O VAL B 322 N LYS B 315 SHEET 3 AB3 3 LEU B 361 THR B 363 -1 O CYS B 362 N VAL B 323 SSBOND 1 CYS A 117 CYS A 124 1555 1555 2.03 SSBOND 2 CYS A 283 CYS A 287 1555 1555 2.03 SSBOND 3 CYS A 325 CYS A 362 1555 1555 2.03 SSBOND 4 CYS B 117 CYS B 124 1555 1555 2.03 SSBOND 5 CYS B 283 CYS B 287 1555 1555 2.03 SSBOND 6 CYS B 325 CYS B 362 1555 1555 2.04 LINK ND2 ASN B 141 C1 NAG B 501 1555 1555 1.44 CISPEP 1 THR A 94 PRO A 95 0 -0.83 CISPEP 2 LEU A 183 PRO A 184 0 -7.05 CISPEP 3 PRO A 373 PRO A 374 0 2.24 CISPEP 4 GLY A 376 PRO A 377 0 0.75 CISPEP 5 THR B 94 PRO B 95 0 0.35 CISPEP 6 LEU B 183 PRO B 184 0 -7.28 CISPEP 7 PRO B 373 PRO B 374 0 3.21 CISPEP 8 GLY B 376 PRO B 377 0 1.21 CRYST1 54.334 99.933 146.529 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018405 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010007 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006825 0.00000